The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Interleukin-12 (IL-12) plays a key role in promoting T helper 1 (Th1) responses and subsequent cell-mediated immunity. Given the role of cytokines in the pathogenesis of psychiatric disorders, the dysregulation of IL-12 in these illnesses would be expected. We measured the plasma levels of IL-12 in 102 psychiatric patients (43 schizophrenia, 34 major depression and 25 bipolar disorder) and 85 normal controls. In addition, IL-12 levels of the patients were measured after an 8-week treatment to assess whether the levels were affected by medication. The IL-12 levels of the patient group with major depression were significantly higher than that of the control group, whereas no differences were found among the other groups. IL-12 values of the three patient groups decreased significantly after 8 weeks of treatment. These findings support the hypothesis that activation of the inflammatory response system and in particular of Th-1-like cells, is involved in the pathophysiology of major depression and that repeated administration of antidepressive and antipsychotic drugs may suppress IL-12 plasma concentrations in psychiatric patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated pro-inflammatory cytokines had been reported to be associated with greater symptom burden in BD (14, 15), and correlation between severity of affective symptoms and serum levels of IL-6, sIL-2R, sIL-6R, TNF-α and tumor necrosis factor receptor 60 and 80 kDa (sTNFR60/80) was found in several studies (16–21).”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [19]
In the citing paper
“there was a significant decrease in IL-12 plasma levels after eight weeks of antidepressant pharmacotherapy [118].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
In the citing paper
“the plasma levels of IL-12 were significantly higher in patients with depression compared to controls”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Self-citationInterleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
Maes, M., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W., & Scharpé, S. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02915-0 · Cited by 341
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6
Lin, A., Kenis, G., Bignotti, S., Tura, G.-J.-B., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., & Maes, M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 306
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
SŁUŻEWSKA, A., RYBAKOWSKI, J. K., LACIAK, M., MACKIEWICZ, A., SOBIESKA, M., & WIKTOROWICV, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32372.x · Cited by 306
Mikova, O., Yakimova, R., Bosmans, E., Kenis, G., & Maes, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00081-5 · Cited by 305
The monocyte-T-lymphocyte hypothesis of major depression
Maes, M., Smith, R., & Simon, S. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00066-j · Cited by 299
Cytokine Production and Serum Proteins in Depression
SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244
Immune‐inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine
Maes, M., Meltzer, H. Y., & Bosmans, E. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01527.x · Cited by 237
Effects of Clozapine on Plasma Cytokine and Soluble Cytokine Receptor Levels
Pollmacher, T., Hinze-Selch, D., & Mullington, J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00011 · Cited by 232
The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence
Smith, R. S., & Maes, M. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90062-4 · Cited by 224
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Ganguli, R., Yang, Z., Shurin, G., Chengappa, K. N. R., Brar, J. S., Gubbi, A. V., & Rabin, B. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90042-6 · Cited by 222
Cytokines, Stress, and Depression: Conclusions and Perspectives
Dantzer, R., Wollman, E. E., Vitkovic, L., & Yirmiya, R. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_17 · Cited by 220
Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
Mittleman, B. B., Castellanos, F. X., Jacobsen, L. K., Rapoport, J. L., Swedo, S. E., & Shearer, G. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2994 · Cited by 218
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1291 · Cited by 204
Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.9.1408 · Cited by 185
Self-citationImmunobiology of lnterleukin-12
Trinchieri, G. (1998) · Immunologic Research · doi:10.1007/bf02786451 · Cited by 184
In vivo immunomodulatory effects of clozapine in schizophrenia
Maes, M., Bosmans, E., Kenis, G., De Jong, R., Smith, R. S., & Meltzer, H. Y. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00057-1 · Cited by 178
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174
Wilke, I., Arolt, V., Rothermundt, M., Weitzsch, C., Hornberg, M., & Kirchner, H. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190280 · Cited by 171
Kim, Y.-K., Kim, L., & Lee, M.-S. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00171-1 · Cited by 158
Self-citationThe role of immune function in schizophrenia: an overview
Müller, N., Riedel, M., Ackenheil, M., & Schwarz, M. J. (1999) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/pl00014187 · Cited by 158
Maes, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00062-0 · Cited by 156
Song, C., Lin, A., Kenis, G., Bosmans, E., & Maes, M. H. J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00116-4 · Cited by 144
Riches, P. G., Gooding, R. P., Millar, B. C., & Rowbottom, A. W. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90314-j · Cited by 141
Sluzewska, A., Sobieska, M., & Rybakowski, J. K. (2008) · Neuropsychobiology · doi:10.1159/000119332 · Cited by 134
Arolt, V., Rothermundt, M., Wandinger, K.-P., & Kirchner, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000650 · Cited by 128
Ganguli, R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950200058014 · Cited by 123
Maes, M. H. J., Bosmans, E., Ranjan, R., Vandoolaeghe, E., Meltzer, H. Y., LEY, M. D., Berghmans, R., Stans, G., & Desnyder, R. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00029-1 · Cited by 120
Activation of indices of cell-mediated immunity in bipolar mania
Tsai, S., Chen, K.-P., Yang, Y., Chen, C., Lee, J.-C., Singh, V. K., & Leu, S.-J. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00159-0 · Cited by 112
Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
Cazzullo, C. L., Scarone, S., GRASSI, B., Vismara, C. S., Trabattoni, D., Clerici, M., & Clerici, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00059-1 · Cited by 108
Immune parameters in rapid cycling bipolar patients before and after lithium treatment
Rapaport, M. H., Guylai, L., & Whybrow, P. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00007-2 · Cited by 107
The effects of lithium on ex vivo cytokine production
Rapaport, M. H., & Manji, H. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01144-1 · Cited by 106
Interleukin-12 an integral cytokine in the immune response
STERN, A. S., Magram, J., & Presky, D. H. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)80003-8 · Cited by 105
Immunological Dysfunction in Schizophrenia: A Systematic Approach
Rothermundt, M., Arolt, V., Weitzsch, C., Eckhoff, D., & Kirchner, H. (1998) · Neuropsychobiology · doi:10.1159/000026501 · Cited by 104
Short and long term immunosuppressive effects of clozapine and haloperidol
Leykin, I., Mayer, R., & Shinitzky, M. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00037-4 · Cited by 101
Accumulation of Macrophages in the CSF of Schizophrenic Patients During Acute Psychotic Episodes
Nikkil⺯, H. V., M�, K., Ahokas, A., Miettinen, K., Rimón, R., & Andersson, L. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1725 · Cited by 98
Elevated interleukin-6 in schizophrenia
van Kammen, D. P., McAllister, C. G., Kelley, M. E., Gurklis, J. A., & Yao, J. K. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00053-0 · Cited by 93
Cytokine profiles in drug-naive schizophrenic patients
Cazzullo, C. L., Sacchetti, E., Galluzzo, A., Panariello, A., Colombo, F., Zagliani, A., & Clerici, M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00046-3 · Cited by 80
Neutrophil and monocyte phagocytosis in depressed patients
McAdams, C., & Leonard, B. E. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90024-m · Cited by 78
Serum interleukin-18 levels are elevated in schizophrenia
Tanaka, K. F., Shintani, F., 藤井, 康., Yagi, G., & Asai, M. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00196-7 · Cited by 78
Decreased Interleukin-2 Production in Korean Schizophrenic Patients
Kim, Y. K., Lee, M. S., & Suh, K. Y. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00357-0 · Cited by 66
Self-citationBlood–cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia
Schwarz, M., Ackenheil, M., Riedel, M. J., & Müller, N. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00655-7 · Cited by 51
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90215-k · Cited by 49
Jongh, R. D., Vranken, J., Vundelinckx, G., Bosmans, E., Maes, M. H. J., & Heylen, R. J. (1997) · Cytokine · doi:10.1006/cyto.1997.0217 · Cited by 45
Janmohamed, S., & Grossman, A. B. (2002) · CRC Press eBooks · doi:10.1201/b15291-19 · Cited by 44
Relationship between immune and behavioral measures in schizophrenia
van Kammen, D. P., McAllister, C. G., & Kelley, M. E. (1997) · Key topics in brain research · doi:10.1007/978-3-7091-6870-7_7 · Cited by 39
Major Depression and activation of the Inflammatory Response System
West, D. V. (1999) · VUBIR (Vrije Universiteit Brussel) · Cited by 10
Research works printed but not linked: 2
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn) American Psychiatric Press: Washington DC 1994
- First MB, Gibbon M, Spitzer RL, Williams JBW . Structural Clinical Interview for DSM-IV Research Version Biometric Research Department, New York Psychiatric Institute: New York 1998
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Metadata
- Authors
- Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J.
- Affiliations
- Korea University Ansan Hospital (KR)
- Korea University (KR)
- Yongin Mental Hospital (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Kim, H
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2002-12-01
- Volume
- 7
- Issue
- 10
- Pages
- 1107-1114
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1992868687
- Cited by
- 224
- References
- 62
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 19
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- IL-12, schizophrenia, major depressive disorder, bipolar mania, psychotropic drugs, antidepressants, antipsychotic drugs, cytokines, Th1 response, plasma cytokines
- MeSH terms
- Adolescent, Adult, Aged, Bipolar Disorder, Depressive Disorder, Female, Humans, Male, Middle Aged, Psychotropic Drugs, Reference Values, Schizophrenia, Th1 Cells, Interleukin-12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.